Entity
  • Agios Pharmaceuticals

    Created in 2008
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    2,610 83,487
  • Activities

  • Technologies

  • Entity types

  • Location

    88 Sidney St, Cambridge, MA 02139, USA

    Cambridge

    United States of America

  • Employees

    Scale: 201-500

    Estimated: 597

  • Engaged corporates

    9
    2 4
  • Added in Motherbase

    5 years, 9 months ago
Description
  • Value proposition

    Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases.

    Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies.

    We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.



    Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias

  • Agios

    Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Our legacy is rooted in a powerful set of strengths, values and competencies. We have built on our core differentiators to make a positive difference for patients through truly differentiated therapies. This foundation will remain constant at Agios and accelerate our impact moving forward.

  • https://www.agios.com/
Corporate interactions BETA
Corporate TypeTweets Articles
 EU Green Capital
EU Green Capital
European Union, Environmental Services
EU Green Capital
European Union, Environmental Services
Other

18 Dec 2024


Pharma IQ
Pharma IQ
Pharmaceutical, Pharmaceutical Manufacturing
Pharma IQ
Pharmaceutical, Pharmaceutical Manufacturing
Other

31 May 2023


Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

20 Sep 2019


Incyte
Incyte
Pharmaceutical, Pharmaceutical Manufacturing
Incyte
Pharmaceutical, Pharmaceutical Manufacturing
Other

8 Mar 2022


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

16 Apr 2018


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Not capitalistic
Not partnership
Event

13 Aug 2018


Boston Consulting Group (BCG)
Boston Consulting Group (BCG)
Consulting, Business Consulting and Services
Boston Consulting Group (BCG)
Consulting, Business Consulting and Services
Not capitalistic
Partnership
Event

24 Jul 2020


Vertex Pharmaceuticals
Vertex Pharmaceuticals
Biotechnology, Biotechnology Research
Vertex Pharmaceuticals
Biotechnology, Biotechnology Research
Not capitalistic
Partnership
Event

23 Feb 2021


Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Not event

21 Dec 2020

17 Mar 2023



Similar entities
Loading...
Loading...
Social network dynamics